These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10876053)

  • 21. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat.
    Gronier B; Rasmussen K
    Br J Pharmacol; 1998 Jun; 124(3):455-64. PubMed ID: 9647468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological and functional characterization of muscarinic receptors in the frog pars intermedia.
    Garnier M; Lamacz M; Galas L; Lenglet S; Tonon MC; Vaudry H
    Endocrinology; 1998 Aug; 139(8):3525-33. PubMed ID: 9681504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of nicotinic and muscarinic acetylcholine receptors on striatal HgCl2-induced dopamine release in freely moving rats.
    Vidal L; Durán R; Faro LR; Alfonso M
    Toxicol Lett; 2008 May; 178(3):181-4. PubMed ID: 18439770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The selective m1 muscarinic antagonist MT-7 blocks pilocarpine-induced striatal Fos expression.
    Wirtshafter D
    Brain Res; 2006 Apr; 1085(1):127-31. PubMed ID: 16564505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pilocarpine on striatal acetylcholine release in dopamine-depleted rats.
    Murakami Y; Matsumoto K; Watanabe H
    Biol Pharm Bull; 1997 Jan; 20(1):88-90. PubMed ID: 9013815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of muscarinic, rather than nicotinic, receptors impairs attention, but does not interact with serotonin depletion.
    Ruotsalainen S; Miettinen R; MacDonald E; Koivisto E; Sirviö J
    Psychopharmacology (Berl); 2000 Feb; 148(2):111-23. PubMed ID: 10663425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of dopamine D1 and D2 receptors on striatal acetylcholine release in rats.
    Ikarashi Y; Takahashi A; Ishimaru H; Arai T; Maruyama Y
    Brain Res Bull; 1997; 43(1):107-15. PubMed ID: 9205804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
    Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors.
    Hamrouni AM; Gudka N; Broadley KJ
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):275-84. PubMed ID: 16879493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects and interactions between alpha-MSH and MCH/NEI upon striatal cAMP levels.
    Sanchez MS; Cremer MC; Celis ME
    Peptides; 1999; 20(5):611-4. PubMed ID: 10465513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between muscarinic receptor subtypes and cyclic nucleotides in pons-medulla oblongata.
    Ge XQ; Hu G; Yao B; Xu PC; Bian CF
    Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):408-11. PubMed ID: 8701755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation.
    Calabresi P; Centonze D; Gubellini P; Pisani A; Bernardi G
    Eur J Neurosci; 1998 Sep; 10(9):2887-95. PubMed ID: 9758158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed nicotinic-muscarinic properties of the alpha9 nicotinic cholinergic receptor.
    Verbitsky M; Rothlin CV; Katz E; Elgoyhen AB
    Neuropharmacology; 2000 Oct; 39(13):2515-24. PubMed ID: 11044723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release.
    Kaiser S; Wonnacott S
    Mol Pharmacol; 2000 Aug; 58(2):312-8. PubMed ID: 10908298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral administration of CDP-choline and its cholinergic metabolites increases serum insulin: muscarinic and nicotinic acetylcholine receptors are both involved in their actions.
    Ilcol YO; Cansev M; Yilmaz MS; Hamurtekin E; Ulus IH
    Neurosci Lett; 2008 Jan; 431(1):71-6. PubMed ID: 18162319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbachol-induced inositol phosphate formation in rat striatum is mediated by both M1 and M3 muscarinic receptors.
    de la Vega MT; Nuñez A; Arias-Montaño JA
    Neurosci Lett; 1997 Sep; 233(2-3):69-72. PubMed ID: 9350834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscarinic Acetylcholine Receptors Inhibit Fyn Activity in the Rat Striatum In Vivo.
    Mao LM; Faris HJ; Wang JQ
    J Mol Neurosci; 2018 Apr; 64(4):523-532. PubMed ID: 29532369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum.
    Harsing LG; Zigmond MJ
    Brain Res Bull; 1998 Apr; 45(6):607-13. PubMed ID: 9566505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB; Reuben M
    Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation by adenosine of both muscarinic M1-facilitation and M2-inhibition of [3H]-acetylcholine release from the rat motor nerve terminals.
    Oliveira L; Timóteo MA; Correia-de-Sá P
    Eur J Neurosci; 2002 Jun; 15(11):1728-36. PubMed ID: 12081652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.